Tividenofusp alfa
Based on 1 Customer Validation
Tividenofusp alfa (DNL‑310) is a modified iduronate‑2‑sulfatase fusion protein capable of crossing the blood-brain barrier. Tividenofusp alfa can be used in research on mucopolysaccharidosis type II.
For research use only. We do not sell to patients.
- Purity: 99.47%
- CAS No.: 2641020-57-5
- Molecular Weight:110.33 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Fusion-Homo sapiens IDS Pr26-550-IGHG1 Fc
Tividenofusp alfa is administered intravenously, reduces heparan sulfate in cerebrospinal fluid and urine, improves cognition, controls somatic lesions, and is well tolerated[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
CPCA_PROTEIN-FC
Chemical Information
-
CAS No. 2641020-57-5
-
Appearance Liquid
-
Molecular Weight 110.33 kDa
-
Color Colorless to light yellow
-
Synonyms
DNL-310
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)